PIPELINE
 | Materializing the potentials of cell therapy
At Help Therapeutics, we harness the potentials of stem cells to develop the next generation medicine. We believe our platform has the potential to reshape cellular medicine. |
HiCM-188: Cell Therapy for Heart Failure
Why Heart Failure?
Heart failure is a life-threatening disease condition endangering over 30 million individuals worldwide. Heart transplantation is the only effective treatment available, but is severely hindered by the lack of donors. Currently, fewer than 1% of Heart Failure patients may receive transplantation.
Our Solution
Our patented technologies allows for the derivation of highly pure cardiomyocytes from induced pluripotent stem cells (iPSCs). Transplantation of these cardiomyocytes promotes heart regeneration and functional recovery in non-human primates.
In 2019, Help Therapeutics initiated first-in-man clinical study involving the transplantation of iPSC-derived cardiomyocytes into heart failure patients, as reported by Nature News.
